Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nadia Yousaf"'
Autor:
Stefan Diem, Lavinia Spain, Dharmisha Chauhan, Nadia Yousaf, James Clark, Ella Daniels, Nick Powell, David M Favara, Lewis Au, Samra Turajlic, James Larkin
Publikováno v:
ESMO Open, Vol 5, Iss 4 (2020)
ESMO Open
ESMO Open
Background Immune-related diarrhoea/colitis (ir-D/C) is a common adverse event of immune checkpoint inhibitor (ICI) therapy. Guidelines recommend corticosteroid (CS) treatment; however, the average treatment duration for ir-D/C remains poorly defined
Autor:
Martin Gore, Mark A Samaan, Sophie Papa, Lavinia Spain, Nadia Yousaf, Tim Raine, James Larkin, Bu'Hussain Hayee, Nick Powell, James O. Lindsay, Polychronis Pavlidis, Hajir Ibraheim, Richard A Speight, Lucy Eldridge, Samra Turajlic, Nikki Hunter, Peter M. Irving, Oliver Brain, Michael Green
Publikováno v:
The lancet. Gastroenterologyhepatology. 5(7)
Immune checkpoint inhibitors are a novel class of cancer treatment that have improved outcomes for a subset of cancer patients. They work by antagonising inhibitory immune pathways, thereby augmenting immune-mediated antitumour responses. However, im
Autor:
Andrew Hodgkiss, Daisy Mak, Rajesh Kumar, Mary O'Brien, Jaishree Bhosle, R. Gunapala, D. Walder, Sanjay Popat, Anna Minchom, Nadia Yousaf
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225509 (2019)
PLoS ONE
PLoS ONE
ObjectivesVitamin supplementation reduces pemetrexed toxicity. Raised plasma homocysteine reflects deficiency in vitamin B12 and folate, and is suppressed by supplementation. This observational study of 112 patients receiving pemetrexed-based chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e046f9ea3d71181c425ae210843e43d4
http://hdl.handle.net/10044/1/76786
http://hdl.handle.net/10044/1/76786
Autor:
Mary O'Brien, S. Page, C. Milner-Watts, Jaishree Bhosle, Michael Davidson, Wanyuan Cui, Anna Minchom, Sanjay Popat, Nadia Yousaf, S. Saith, I. Locke
Publikováno v:
Journal of Thoracic Oncology
Autor:
James Larkin, Nadia Yousaf, Lewis Au, Hajir Ibraheim, Muhammad Waqas Fazal, Lavinia Spain, Nick Powell, Samra Turajlic, Martin Gore
Publikováno v:
IBD.
Introduction Immune Checkpoint inhibitors (ICPi) have revolutionised the management of melanoma, non-small cell lung cancer and renal cancer. They block receptors expressed by immune cells that reduce immune activation. ‘Turbo-charged’ immune cel
Autor:
James Larkin, Amit Samani, Martin Gore, Hajir Ibraheim, Nick Powell, Sophie Papa, Lavinia Spain, Nadia Yousaf, Samra Turajlic
Publikováno v:
IBD.
Background Immune check point inhibitors (ICPis) have transformed the treatment landscape for several cancers, but at the cost of triggering ICPi-induced colitis which resembles some aspects of IBD. Diagnosis is often made by symptoms, or by identify